: Panmure Gordon reduces target price from 2159p to 1742p and reiterates its hold recommendation.
[27 Feb '13]Admiral Group: Investec takes target price from 570p to 582p, but still recommends selling.
[19 Feb '13]Afren: Morgan Stanley takes target price from 215p to 220p and reiterates an overweight rating.
[10 Jan '13]A round-up of the biggest director buys today so far.
[20 Dec '12]Sinclair IS Pharma has signed a 10-year deal with Biocodex to expand its dermatology portfolio in Russia, Turkey and Europe's Benelux countries.
[19 Dec '12]A round-up of the biggest director buys today so far.
[18 Dec '12]Aggreko, Alliance Pharma, Avacta, Barclays, BP, Bunzl, Burberry, Capita, Chariot, CRH, Debenhams, Dechra, Drax, EMIS, Go-Ahead, Imperial, Inmarsat, Johnson Service, Jupiter, Keller, Lancashire, Lloyds, Man, McBride, Morrison, Rank, Redrow, Rockhopper, RBS, Sinclair, Spectris, St James's Place, Standard Life, UBM, Vertu, Whitbread, William Hill
[19 Oct '12]Barclays, BATS, Capco, Charles Stanley, Electrocomponents, HSBC, JD Wetherspoon, Lloyds, Petropavlovsk, RBS, Sinclair, Spectris, Sportingbet, StanChart, Tesco, Weir
[1 Oct '12]